Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Code:
NCT06027086
Conditions
Fibrolamellar Hepatocellular Carcinoma
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Durvalumab
DRP-104
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-17. This information was provided to ClinicalTrials.gov by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins on 2025-12-03.